fda semaglutide update says that the GLP-1 shortage is over fda semaglutide shortage status january

That new pathway needs its own adjustment period

We understand that a prediabetes diagnosis can feel overwhelming, but it is also a powerful window of opportunity

Thats fineIve spent three decades in that spacebut it means YOU are responsible for educating yourself, sourcing quality compounds, and monitoring your own response

Discussion This study adds to the limited available data on the use of semaglutide in patients with advanced CKD and provides insight over a prolonged follow-up period exceeding three years (median 1,187 days [IQR 6021,442]), with the majority of patients receiving maintenance hemodialysis (58.8%)